Unlock instant, AI-driven research and patent intelligence for your innovation.

Neurotensin-induced tumor formation is regulated by micro RNA 133a-aftiphilin-dependent receptor recycling

Inactive Publication Date: 2016-04-14
RGT UNIV OF CALIFORNIA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes methods for treating and diagnosing colorectal cancer and inflammatory bowel disease using antisense miR-133α and a polypeptide called AFTPH. The patent also describes the use of lentivirus to express the antisense miR-133α and AFTPH genes. The technical effects of the patent include improved treatment and diagnosis of colorectal cancer and inflammatory bowel disease using novel methods.

Problems solved by technology

However, due to the multi factorial nature of the disease, flare-ups of the disease and side effects associated with the different treatment approaches, in particular corticosteroids are common.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Neurotensin-induced tumor formation is regulated by micro RNA 133a-aftiphilin-dependent receptor recycling
  • Neurotensin-induced tumor formation is regulated by micro RNA 133a-aftiphilin-dependent receptor recycling
  • Neurotensin-induced tumor formation is regulated by micro RNA 133a-aftiphilin-dependent receptor recycling

Examples

Experimental program
Comparison scheme
Effect test

example 1

NT-Induced miR-133α Upregulation is Involved in NTR1 Recycling

[0164]We have previously shown that NT induces the differential expression of microRNAs in human colonocytes NT (Bakirtzi, K., et al., 2011. Neurotensin Signaling Activates MicroRNAs-21 and -155 and Akt, Promotes Tumor Growth in Mice, and Is Increased in Human Colon Tumors. Gastroenterology 141:1749-1761.e1741) within a time period that coincides with NTR1 internalization and recycling (Law, I. K. M., et al., 2012. Neurotensin-induced pro-inflammatory signaling in human colonocytes is regulated by beta-arrestins and endothelin-converting enzyme-dependent endocytosis and re-sensitization of NT receptor 1. Journal of Biological Chemistry). Therefore, we investigated whether the NT—up-regulated microRNAs (miRs: 140, 21, 210, 155, 133α, 23α, 23β, 331-5p) (Bakirtzi, K., et al., 2011. Neurotensin Signaling Activates MicroRNAs-21 and -155 and Akt, Promotes Tumor Growth in Mice, and Is Increased in Human Colon Tumors. Gastroenter...

example 2

MiR-133α Directly Regulates AFTPH Expression through Binding its 3′ UTR in Colonic Epithelial Cells

[0168]MicroRNAs act as gene-silencers by inducing the degeneration of mRNA transcripts through their binding to the 3′ UTRs of the target genes (McKenna, et al., 2010. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 139:1654-1664, 1664 e1651). Therefore, we next searched for genes with possible miR-133α binding sites in their 3′ UTRs.

[0169]In silico search using 3 online databases: TargetScanHuman; miRBase and PicTar identified aftiphilin (AFTPH) with a miR-133α binding site at its 3′ UTR that was highly conserved across different species (FIG. 4A). This interaction was validated experimentally in human colonocytes. Specifically, miR-133α induction by NT treatment of NCM460-NTR1 cells resulted in down-regulation of AFTPH mRNA levels and its 3′ UTR-associated luciferase activity. However this effect was lost in the presence o...

example 3

Trans-Golgi Network (TGN)-Localized AFTPH Expression Modulates NT-miR133α-Regulated NTR1 Recycling

[0171]AFTPH is a 936 amino acid protein with binding motifs for clathrin (Dell'Angelica, E. C., 1998. Association of the AP-3 adaptor complex with clathrin. Science 280:431-434), adaptor protein-1 (AP-1) and AP-2 (Mattera, R., et al., 2004. Definition of the consensus motif recognized by gamma-adaptin ear domains. J Biol Chem 279:8018-8028), key mediators of endocytosis and exocytosis. Endogenous AFTPH was prominently colocalized with the TGN marker TGN38 in NCM460-NTR1 cells (FIG. 5A), in agreement with previous observations in neurons (Burman, J. L., et al., 2005. Aftiphilin is a component of the clathrin machinery in neurons. FEBS Lett 579:2177-2184), and was partially colocalized with NTR1 in human NCM460-NTR1 colonocytes (FIG. 5B).

[0172]To investigate the role of AFTPH in NT-induced NTR1 internalization and recycling, AFTPH expression in NCM460-NTR1 cells was knocked down by AFTPH ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
v/vaaaaaaaaaa
v/vaaaaaaaaaa
affinityaaaaaaaaaa
Login to View More

Abstract

This application discloses methods of treating, preventing, and diagnosing colorectal cancer and IBD in a subject comprising administering an effective dose of antisense miR-133α or AFTPH to the subject or detecting expression levels of miR-133α and AFTPH.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]The present application claims priority to U.S. Provisional Application No. 61 / 824,603, filed May 17, 2013, which is incorporated by reference herein in its entirety for all purposes.GOVERNMENT RIGHTS[0002]This invention was made with Government support of Grant No. DK60729, awarded by the National Institutes of Health. The Government has certain rights in the invention.FIELD OF THE INVENTION[0003]Colorectal cancer (CRC) is one of the most common cancers in the developed world with an overall incidence of 5% in the general population. The 5-year survival rate ranges from 40-60%, although surgical intervention can cure up to 90% of patients if the disease is detected at the early stage. Currently, fecal occult blood test (FOBT), sigmoidoscopy, colonoscopy and double contrast barium enema (DCBE) are used for CRC screening, but in some cases, small polyps may be missed. Therefore, intense research efforts are focusing in the development of n...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68A61K38/17C12N15/113
CPCC12Q1/6886C12N15/113A61K38/1709C12Q1/6883C12N2320/30C12Q2600/178C12N2310/113C12N2310/3231C12Q2600/158C12N2310/14A61K38/00A61P35/00C07K14/47C12N15/1135C12N15/86C12N2310/11C12N2310/141C12N2740/15043
Inventor POTHOULAKIS, CHARALABOSILIOPOULOS, DIMITRIOSLAW, KA MAN
Owner RGT UNIV OF CALIFORNIA